KPIC defies new drug pricing plan

The Korea Pharmaceutical Industry Cooperative has reaffirmed their intention to oppose a new positive list system, while calling for the government to protect the benefits of small- and medium-sized drug companies.

The KPIC argues that once the price of all generic drugs is to be lowered by 20 percent to ensure better stability of the national insurance fund, small- and medium-sized drug mak...